GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
Oklahoma man Cody Adams, 33, faces manslaughter charge after authorities say his bullet from target practice killed Sandra Phelps on Christmas Day....
The European Union and South Korea are facing increasing pressure from the administration over their unfair treatment of U.S. tech firms....
President Donald Trump's Cabinet has largely remained stable during his second term in the White House. Who has performed well and who has flailed?...
